US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 ...
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
GSK received approval from the Food and Drug Administration for Blujepa to be used as a treatment for some urinary tract infections. Blujepa, or gepotidacin, was approved to treat uncomplicated ...
The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract ...
New York Attorney General Letitia James on Tuesday urged 23andMe customers to secure their data in light of rising privacy ...
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
After continued poor sales of its ancestry testing kits, the U.S. firm sought to keep afloat with $35 million of financing ...
On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The ...
This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,600 state and federal courts. Click here to get started and be first to act on ...
The FDA approved oral gepotidacin (Blujepa) for uncomplicated urinary tract infections (UTIs) in women and girls ages 12 ...
It was a simple promise: for $99, your DNA would reveal your ancestry, some genetic traits, even your health risks. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback